Article

Use of testosterone therapy in hypogonadal men with prostate cancer

Just a few years ago, it would have been unthinkable to offer testosterone therapy (TTh) to men with a history of prostate cancer. Yet several changes have occurred to make TTh a reasonable treatment option in men who are symptomatic from testosterone deficiency.

Key Points

The relationship between T and prostate cancer has been a primary interest of mine, and it has been fascinating to watch the transformation in thought and practice over the last 20 years. In this article, I will present our current understanding of this topic and its impact on clinical practice.

Related Videos
Raveen Syan, MD, FPMRS, answers a question during a video interview
Jaspreet S. Sandhu, MD, answers a question during a video interview
J. Quentin Clemens, MD, MSCI, answers a question during a video interview
Timothy Lyon, MD, answers a question during a video interview
Related Content
© 2025 MJH Life Sciences

All rights reserved.